🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07294040
Recruiting Observational

Incidence and Risk Factors of Post-Induction Hypotension in Geriatric Cancer Patients

NCT07294040 · tracked via the Priya Life Science Turkey tracker
Sponsor
Dolunay ARIK
Phase
Observational
Started
2025-05-25
Last updated
2025-12-19

Condition(s) studied

Post-induction Hypotension (PIH)Geriatric PatientOncologic DiseaseHemodynamic Effects of General AnesthesiaRisk Factors Associated With Anesthesia-Induced Hypotension

Study summary

This observational clinical study aims to investigate the incidence and risk factors of post-induction hypotension (PIH) in geriatric cancer patients undergoing surgery under general anesthesia. PIH is defined as a drop in mean arterial pressure of ≥30% from baseline or below 65 mmHg within the first 20 minutes after anesthesia induction, prior to surgical stimulation.

The primary objective is to determine the frequency of PIH in elderly oncology patients. Secondary objectives include evaluating the association of PIH with age, ASA score, cancer type, oncological treatments (chemotherapy/radiotherapy), comorbidities, medication use, anemia, biochemical parameters, and preoperative perfusion index (PI) and pleth variability index (PVI).

Findings from this study are expected to contribute to improved perioperative management and to the development of tailored anesthesia protocols for geriatric oncology patients.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults ≥65 years of age Patients with a diagnosis of cancer and scheduled for surgery Ability and willingness to provide written informed consent ASA physical status class II-IV Exclusion Criteria: Patients under 65 years of age Patients without a confirmed oncologic diagnosis Refusal to provide written informed consent Patients undergoing regional anesthesia Patients with tracheostomy or requiring multiple intubation attempts History of peripheral arterial disease Use of vasopressors before the start of surgery Uncontrolled hypertension (blood pressure \>180/110 mmHg) Advanced heart failure (Ejection Fraction \<40%) Severe arrhythmias such as atrial fibrillation or significant ventricular arrhythmias that preclude reliable hemodynamic monitoring

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Ankara Ankara Recruiting

More Dolunay ARIK trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07294040 on ClinicalTrials.gov ↗ ← All trials in Turkey